Subsequent studies have provided evidence that the transforming growth factor-beta1 (TGF-β1) augments L1CAM expression in pancreatic and endometrial cancer cells, which is dependent on Slug, a transcription factor that modulates epithelial-mesenchymal transition [33–35]. This evidence concerns the gene L1CAM and endometrial cancer.